Table 1

Patientcharacteristics by opioid exposure status in the year before surgery

Opioid-naïve participantsOpioid-exposed participantsOverallP value
Sample size, n19,201680026,001
Demographics
Mean age (SD) in years53.9 (16.6)53.6 (15.9)53.8 (16.4)0.11
Age categories in years, n (%)
18–291753 (9)548 (8)2301 (9)<0.001
30–392397 (12)931 (14)3328 (13)
40–493274 (17)1275 (19)4549 (17)
50–593977 (21)1346 (20)5323 (20)
60–642203 (11)787 (12)2990 (11)
≥655597 (29)1913 (28)7510 (29)
Sex, n (%)<0.001
Female10,506 (55)4270 (63)14,776 (57)
Male8695 (45)2530 (37)11,225 (43)
Race/ethnicity, n (%)<0.001
White, non-Hispanic15,885 (83)5682 (84)21,567 (83)
Black, non-Hispanic1452 (8)614 (9)2066 (8)
Hispanic510 (3)188 (3)698 (3)
Other/unknown1354 (7)316 (5)1670 (6)
Insurance type, n (%)<0.001
Private10,273 (54)3016 (44)13,289 (51)
Medicare5442 (28)2084 (31)7526 (29)
Medicaid2594 (14)1401 (21)3995 (15)
Medicare and Medicaid268 (1)169 (2)437 (2)
Other624 (3)130 (2)754 (3)
Patient characteristics
ASA classification, n (%)<0.001
11986 (10)354 (5)2340 (9)
211 251 (59)3552 (52)14 803 (57)
35660 (29)2728 (40)8388 (32)
4 or 5287 (1)159 (2)446 (2)
Unknown17 (<1)7 (<1)24 (<1)
Body mass index, n (%)<0.001
<253803 (20)1222 (18)5025 (19)
25 to <306229 (32)1933 (28)8162 (31)
30 to <354692 (24)1692 (25)6384 (25)
≥354427 (23)1942 (29)6369 (24)
Unknown50 (<1)11 (<1)61 (<1)
Tobacco use, n (%)3504 (18)1678 (25)5182 (20)<0.001
Ascites, n (%)44 (<1)18 (<1)62 (<1)0.61
Bleeding disorder, n (%)140 (1)71 (1)211 (1)0.01
Congestive heart failure, n (%)48 (<1)22 (<1)70 (<1)0.31
Coronary artery disease, n (%)726 (4)360 (5)1086 (4)<0.001
Chronic obstructive pulmonary disease, n (%)649 (3)466 (7)1115 (4)<0.001
Diabetes, n (%)2111 (11)906 (13)3017 (12)<0.001
Dialysis use, n (%)41 (<1)33 (<1)74 (<1)<0.001
Deep vein thrombosis/pulmonary embolus, n (%)175 (1)133 (2)308 (1)<0.001
Hypertension, n (%)7079 (37)3005 (44)10 084 (39)<0.001
Cancer, n (%)1038 (5)418 (6)1456 (6)0.02
Functional status, n (%)19 064 (99)6755 (99)25 819 (99)0.66
Sleep apnea, n (%)3971 (21)1764 (26)5735 (22)<0.001
Pneumonia, n (%)7 (<1)6 (<1)13 (<1)0.13
Immunosuppressed, n (%)316 (2)227 (3)543 (2)<0.001
Recent weight loss, n (%)42 (<1)22 (<1)64 (<1)0.13
Peripheral vascular disease, n (%)74 (<1)65 (1)139 (1)<0.001
Clinical characteristics
Procedure type, n (%)<0.001
Abdominal hernia859 (4)445 (7)1304 (5)
Laparoscopic appendectomy2282 (12)498 (7)2780 (11)
Laparoscopic cholecystectomy5649 (29)2188 (32)7837 (30)
Laparoscopic colectomy886 (5)328 (5)1214 (5)
Laparoscopic hysterectomy1742 (9)765 (11)2507 (10)
Minor hernia5830 (30)1814 (27)7644 (29)
Open colectomy480 (2)184 (3)664 (3)
Total abdominal hysterectomy570 (3)231 (3)801 (3)
Vaginal hysterectomy903 (5)347 (5)1250 (5)
Surgical priority, n (%)<0.001
Elective14 168 (74)5393 (79)19 561 (75)
Emergent/Urgent5033 (26)1407 (21)6440 (25)
Length of stay, n (%)0.33
09803 (51)3409 (50)13 212 (51)
14419 (23)1554 (23)5973 (23)
22005 (10)734 (11)2739 (11)
31147 (6)453 (7)1600 (6)
4707 (4)261 (4)968 (4)
≥51120 (6)389 (6)1509 (6)
  • Opioid-naïve participants did not fill an opioid prescription in the year before surgery. Opioid exposed participants filled at least one opioid prescription in the year before surgery.

  • χ2 statistical test used for all tests with exception of mean age (t-test).

  • ASA, American Society of Anesthesiologists.